Document is current
Any future updates will be listed below
-
Authors
Hossenbaccus, Lubnaa
Linton, Sophia
Garvey, Sarah
Ellis, Anne K. http://orcid.org/0000-0002-0725-2353
- License Information
-
More Information
Article History
Received: 22 January 2020
Accepted: 13 May 2020
First Online: 27 May 2020
Ethics approval and consent to participate
: Not applicable.
: Not applicable.
: LH, SL, and SG have no disclosures. AKE has the following disclosures that pose no conflict of interest to the current manuscript. AKE has participated in advisory boards for ALK Abello, AstraZeneca, Aralez, Bausch Health, Circassia Ltd, GlaxoSmithKline, Johnson & Johnson, Merck, Mylan, Novartis, Pediapharm and Pfizer, has been a speaker for ALK, Aralez, AstraZeneca, Boerhinger-Ingelheim, CACME, Meda, Mylan, Merck, Novartis, Pediapharm, Pfizer, The ACADEMY, and Takeda. Her institution has received research grants from Bayer LLC, Circassia Ltd, Green Cross Pharmaceuticals, GlaxoSmithKline, Sun Pharma, Merck, Novartis, Pfizer, Regeneron and Sanofi. She has also served as an independent consultant to Allergy Therapeutics, Bayer LLC, Ora Inc. and Regeneron in the past. The authors declare that they have no competing interests.
